16 / 27
Landmark 2-year overall survival in OAK
LTS, long-term survivors.
a
27 atezolizumab- and 49 docetaxel-arm patients were censored prior to 24 months and excluded from this analysis.
Data cutoff: 23 January, 2017.
Satouchi, et al. WCLC 2017
16
Overall survival (OS) in ITT850